Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Leukemia & Lymphoma
|
August 3, 2025
KR-acking the code in non-GCB DLBCL?
Adrian Minson, Jeremy Abramson
JCO Global Oncology
|
December 3, 2021
Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana
Fallon E Chipidza, Mukendi K A Kayembe, Isaac Nkele, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2007
The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
Przemyslaw Juszczynski, Jing Ouyang, Stefano Monti, et al.
Plos One
|
May 11, 2018
Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation
Louise E Hogan, Emily Hanhauser, Kristen S Hobbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)
Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.
Nature Reviews. Clinical Oncology
|
December 30, 2016
The landscape of new drugs in lymphoma
Anas Younes, Stephen Ansell, Nathan Fowler, et al.
Neurology
|
February 20, 2025
Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy
Thomas A Nelson, Naina K Murthy, Maria Martinez-Lage, et al.
Neurology
|
October 4, 2024
Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy
Thomas A Nelson, Naina K Murthy, Maria Martinez-Lage, et al.
Blood
|
July 20, 2019
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma
Matthew J Frigault, Jorg Dietrich, Maria Martinez-Lage, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 27, 2015
Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma
Yi-Bin Chen, Shuli Li, David C Fisher, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Leukemia & Lymphoma
|
August 3, 2025
KR-acking the code in non-GCB DLBCL?
Adrian Minson, Jeremy Abramson
JCO Global Oncology
|
December 3, 2021
Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana
Fallon E Chipidza, Mukendi K A Kayembe, Isaac Nkele, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 3, 2007
The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
Przemyslaw Juszczynski, Jing Ouyang, Stefano Monti, et al.
Plos One
|
May 11, 2018
Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation
Louise E Hogan, Emily Hanhauser, Kristen S Hobbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance)
Ann S LaCasce, Travis Dockter, Amy S Ruppert, et al.
Nature Reviews. Clinical Oncology
|
December 30, 2016
The landscape of new drugs in lymphoma
Anas Younes, Stephen Ansell, Nathan Fowler, et al.
Neurology
|
February 20, 2025
Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy
Thomas A Nelson, Naina K Murthy, Maria Martinez-Lage, et al.
Neurology
|
October 4, 2024
Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy
Thomas A Nelson, Naina K Murthy, Maria Martinez-Lage, et al.
Blood
|
July 20, 2019
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma
Matthew J Frigault, Jorg Dietrich, Maria Martinez-Lage, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 27, 2015
Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma
Yi-Bin Chen, Shuli Li, David C Fisher, et al.
Page
of 2